⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 1, 1996Epidemiology and InfectionOpen Access

Non-replicating expression vectors: applications in vaccine development and gene therapy

Keith Limbach Enzo Paoletti

View Full Paper

Ask AI

Bookmark

Share

Abstract

SUMMARY This review presents experimental, preclinical and clinical data illustrating the multiple uses of recombinant non-replicating virus vectors in the fields of immunoprophylaxis and gene therapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Limbach et al. (1996) studied this question.

synapsesocial.com/papers/6a89007e9f05dd9930a2adf1 https://doi.org/10.1017/s0950268800052547

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Cytolytic T Lymphocyte Responses in Seronegative Adults by a Nonreplicating, Host-Range-Restricted Canarypox Vector (ALVAC) Carrying the HIV-1MN env GeneOriginal Research · 1995 · 101 citations
2Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.Original Research · 1989 · 282 citations
3Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes.Original Research · 1990 · 130 citations
4Retroviral-mediated gene transfer into hepatocytes in vivo.In Vitro Study · 1991 · 285 citations
5Immunogenicity of Recombinant Human Adenovirus-Human Immunodeficiency Virus Vaccines in ChimpanzeesOriginal Research · 1993 · 58 citations

Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.1982
A Prime-Boost Approach to HIV Preventive Vaccine Using a Recombinant Canarypox Virus Expressing Glycoprotein 160 (MN) followed by a Recombinant Glycoprotein 160 (MN/LAI)1995
A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes.1994
Divide and reduce: systematic review and mathematical modelling of the impact of within-farm compartmentalisation on avian influenza transmission in poultryEpidemiology and Infection · 2026
Bat rabies in France: Analysis of national surveillance data reveals contrasting bioclimatic preferences between EBLV-1a and EBLV-1b of the common serotine ( Cnephaeus (Eptesicus) serotinus ) batsEpidemiology and Infection · 2026

More from Epidemiology and Infection

More from Reprogenetics